Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers

NCT03868072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: XELJANZ 5Mg Tablet
DRUG: Chong Kun Dang Tofacitinib Tablet

Sponsor

Chong Kun Dang Pharmaceutical